Company sells equity at $1.00 per share in units priced at $25,000
By Devika Patel
Knoxville, Tenn., Jan. 5 - Echo Therapeutics, Inc. priced a private placement of stock on Nov. 26, according to an 8-K filed Wednesday with the Securities and Exchange Commission. The deal raised $70,000 at pricing, $1.25 million on Dec. 29 and $616,500 on Jan. 4.
The company is selling 120 units of 25,000 common shares and warrants for 25,000 shares at $25,000.00 per unit. It sold 2.8 units in the first tranche, 50 units in the second and 24.66 units in the third.
Of the warrants, half are exercisable at $1.50; the remaining warrants are each exercisable at $2.50. The strike prices reflect 50% and 150% premiums to the Nov. 24 closing share price of $1.00.
Proceeds will be used for working capital and general corporate purposes and to repay a promissory note.
Franklin, Mass.-based Echo Therapeutics is a dual platform-enabled specialty therapeutics and diagnostics company.
| Issuer: | Echo Therapeutics, Inc.
|
| Issue: | Units of 25,000 common shares and warrants for 25,000 shares
|
| Amount: | $3 million
|
| Units: | 120
|
| Price: | $25,000
|
| Warrants: | Warrants for 25,000 shares per unit
|
| Warrant strike prices: | $1.50 (for 12,500 shares), $2.50 (for 12,500 shares)
|
| Pricing date: | Nov. 26
|
| Settlement dates: | Nov. 26 (for $70,000), Dec. 29 (for $1.25 million), Jan. 4 (for $616,500)
|
| Stock symbol: | OTCBB: ECTE
|
| Stock price: | $1.00 at close Nov. 26
|
| Market capitalization: | $44.41 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
